Language
English
Login
We offer our registered users tailored information, free online courses and exclusive content.
Can't find your password?
Reset it here.
Reset it here.
Multiple sclerosis: meeting unmet needs through scientific discoveries and clinical practice
PART OF MS Alumni FEATURE
Multiple sclerosis: meeting unmet needs through scientific discoveries and clinical practice
- Neurology
- Multiple sclerosis
Saturday, Apr 9 - Sunday, Apr 10 2016
Berlin, Germany
Registration status
Closed
To register for this event, contact
Meridiano Congress International (Italy)
Congress Manager: David H. Slangen
T +39 06 88 595 250 - F +39 06 88 595 234
[email protected]
Registration fee
400.00€
Target audiences
Neurologists managing MS patients
Files
Introduction
Overview
Several advances have been made from the clinico-diagnostic, scientific and therapeutic points of view in the multiple sclerosis (MS) field over the past few years. Although new opportunities have been offered to MS patients, new issues are concerning the MS community. Among them, the need to better define therapeutic algorithms and to balance risks and benefits related to the new disease modifying drugs (DMDs) are still of pivotal importance. If the relapsing-remitting phase of MS can benefit from the new DMDs, an effective treatment for the progressive forms is still lacking. Therefore, basic scientists and clinicians have put great effort into trying to better understand the pathogenic mechanisms underlying progressive MS and discover new potential therapeutic targets. The programme will offer a comprehensive overview of MS pathophysiology, diagnosis and treatment as well as give participants the most up-to-date information in basic science, diagnostic workout, clinical management and risk stratification in order to globally improve the lives and health care of MS patients.
Learning objectives
• Describe the main advances in MS pathogenesis
• Discuss the role of different tools in MS diagnosis, monitoring and treatment choices
• Review the mechanisms of neurodegeneration and repair
Accreditation details
EXCEMED (www.excemed.org) is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ® ) to provide the following CME activity for medical specialists. The EACCME ® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
The CME conference “Multiple sclerosis: meeting unmet needs through scientific discoveries and clinical practice” to be held on 9-10 April 2016 in Berlin, Germany, is designated for a maximum of 9 (nine) hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME ® credits are recognized by the American
Medical Association (AMA) towards the Physician's Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.
An application for CME accreditation has been made to the Medical Association Berlin (Ärztekammer Berlin).
Scientific programme
Scientific programme
DAY 1
08.45 EXCEMED opening, D. Bates (UK) – G. Comi (Italy)
Real-time survey
SESSION I: Update on pathogenesis
09.00 L1: Revisiting the role of T and B cells in MS, A. Bar - Or (Canada)
09.20 L2: Variability of MS evolution: the role of genetics and environment, D. Hafler (USA)
09.40 L3: Basic mechanisms of underlying disease “progression”, H. Lassman (Austria)
Discussion
10.20 Coffee break
SESSION II - MS treatment
10.50 L4: Risk minimization, P.S. Sorensen (Denmark)
11.10 L5: MRI as a guide for treatment decisions, N. De Stefano (Italy)
11.30 L6: Visual platforms in clinical trials and patient monitoring, P.Villoslada (Spain)
11.50 L7: How the lab could monitor burden of CD4 and CD5, M. Comabella (Spain)
Discussion
Revisiting real-time survey
12.30 Lunch
Real-time survey
SESSION III -MS treatment
13.30 L8: Methodological aspects in comparing treatment efficacy, L. Kappos (Switzerland)
13.50 L9: How to assess treatment response, M. Tintorè (Spain)
14.10 L10: Revisited induction, G. Comi (Italy)
14.50 Snapshots:
- Current and emerging treatments, A. Chan (Switzerland)
- Emerging MRI techniques and their relationship to clinical outcomes, J. Oh (Canada)
- Managing immunosuppression, S. Schippling (Switzerland)
15.20: Coffee break
SESSION IV - Recovery and rehabilitation
15.50 L11: Myelin repair, S. Bittner (Germany)
16.10 L12: Pharmacology for enhanced recovery, D. Centonze (Italy)
16.30 L13: New basis for rehabilitation, J. Kesselring (Switzerland)
Discussion
Revisiting real-time survey
17.10 End of the day
DAY 2
08.30-10.30
WS1: Instrumental techniques
- MRI – N. De Stefano (Italy)
- Functional tests (VEP) – L. Leocani (Italy)
WS2: Decision making process
- M. Tintorè (Spain)
- G. Comi (Italy)
WS3: Symptomatic treatments
- J. Kesselring (Switzerland)
- P.S. Sørensen (Denmark)
WS4: Fluids biomarkers
- A. Bar ‘Or (Canada)
- L. Kappos (Switzerland)
10.30-11.00 Coffee break
11.00-11.30 Gauging your knowledge and views
11.30-12.00 CLOSING PLENARY LECTURE - New challenges and new frontiers: the PMSA experience, A. J. Thompson (UK)
12.00 Wrap up
12.10 End of the conference
CME provider
EXCEMED - Excellence in Medical Education
EXCEMED is a non profit foundation dedicated, since the last four decades, to the development of high-quality medical education programme all over the world. EXCEMED adheres to the guidelines and standards of the European Accreditation Council for Continuing Medical Education (EACCME ® ) which states that continuing medical education must be balanced, independent, objective, and scientifically rigorous.
Chair(s)
David Bates
Department of Neurology
Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
Giancarlo Comi
Department of Neurology
Institute of Experimental Neurology
Vita-Salute San Raffaele University
Milan, Italy
Speakers
Amit Bar-Or
Neurologist and Professor
Department of Neurology and Neurosurgery
Clinical Research Unit
Montreal Neurological Institute
Montreal, Canada
David Bates
Department of Neurology
Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
Stefan Bittner
Department of Neurology
University of Muenster
Muenster, Germany
Diego Centonze
Neurology Unit
IRCSS Mediterraneo Neuromed Neurology Institute
Rome, Italy
Andrew Chan
St. Joseph Hospital der Ruhr
Bochum, Germany
Manuel Comabella
Multiple Sclerosis Center of Catalonia Unit of Clinical Neuroimmunology
Vall d’Hebron University Hospital
Barcelona, Spain
Giancarlo Comi
Department of Neurology
Institute of Experimental Neurology
Vita-Salute San Raffaele University
Milan, Italy
Nicola De Stefano
Department of Medicine, Surgery & Neuroscience
University of Siena
Siena, Italy
David Hafler
Department of Neurology
Yale School of Medicine
New Haven, United States
Ludwig Kappos
Department of Biomedicine
University Hospital Basel
Basel, Switzerland
Jürg Kesselring
Head of Department of Neurology & Neurorehabilitation
Department of Neurorehabilitation
Valens Clinic Rehabilitation Centre
Valens, Switzerland
Hans Lassman
Department of Neuroimmunology
Medical University of Vienna
Vienna, Austria
Letizia Leocani
Institute of Experimental Neurology
University Vita-Salute IRCCS
Milan, Italy
Jiwon Oh
Division of Neurology
University of Toronto
Canada
Sven Schippling
CRPP Multiple Sclerosis
University of Zurich
Zurich, Switzerland
Alan Thompson
Department of Brain Repair and Rehabilitation
Institute of Neurology
National Hospital for Neurology and Neurosurgery
Queen Square
London, United Kingdom
Per Soelberg Sørensen
Danish Multiple Sclerosis Centre
Rigshospitalet
Copenhagen, Denmark
Mar Tintorè
Neurology-Neuroimmunology Department
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron University Hospital
Barcelona, Spain
Pablo Villoslada
Dept of Neurology
University of California San Francisco
San Francisco (CA), United States
Disclaimer
Publication
Neurology
Neurology
Video
Neurology
